The document discusses alternatives to animal studies in 3 main areas: replacement, reduction, and refinement. Replacement involves using non-animal methods like cell cultures, computer simulations, or chemical/physical systems. Reduction aims to minimize animal use through improved study design and statistics. Refinement focuses on lessening pain and distress for animals, such as by improving surgical techniques or control of variables. A variety of non-animal methods are presented, including in vitro assays, microorganisms, and computer models, as well as strategies for reducing animal numbers through data sharing and statistical practices.
This document discusses alternatives to animal testing for drug development and safety testing. It outlines 4 steps to developing and validating alternative methods: defining the alternative, developing the alternative using in vitro and computer models, validating the methods, and gaining acceptance. Recent advances in stem cells and organ-on-chip models provide more human-relevant alternatives. In vitro tests using human cells, tissues, and organ models can replace animal use for toxicity, efficacy, and disease modeling. Computer models also simulate human biology for drug screening without animals.
Alternative methods to animal toxicity testingSachin Sharma
This document presents information on alternative methods to animal toxicity testing. It discusses the need for alternatives due to the harms animals face in toxicity testing. The 3Rs principles of reduction, refinement and replacement are explained, which aim to minimize animal use and suffering. The validation process for new alternative methods through organizations like ECVAM is covered. Specific alternative methods mentioned include in vitro tests like the Ames test and HET-CAM test, in silico methods, and mathematical models. The HET-CAM test for eye irritation is described in more detail.
This document discusses several alternative methods that can be used instead of animal experiments for pharmacological and toxicological screening. It describes the full thickness skin model method which uses skin tissue to evaluate the effects of substances instead of live animals. It also mentions in silico methods which use computer programs and knowledge of similar substances to predict properties without testing. The document outlines the cell line technique using continuous cell lines to screen for effects like anticancer drugs. Finally, it explains the patch clamp technique which studies individual ion channels in isolated cells and kidney tubules as an alternative to testing on whole animals.
Alternative methods to animal testing: reviewankit sharma
Animals are used in various areas of biomedical science such as teaching, research, and testing of drugs. While animal models provide important insights, they have limitations in translating findings to humans due to interspecies differences. To reduce animal use, alternatives such as computer modeling, tissue cultures, and microdosing are being utilized. The 3Rs principle of replacement, reduction, and refinement is also applied to minimize animal pain and distress when animal use is necessary.
Assignment on Alternatives to Animal Screening MethodDeepak Kumar
Toxicity studies are generally performed to determine drug effects that cannot be evaluated through standard pharmacology profiles or that only occur with repeated administration. Most toxicity tests are performed in two species, such as a rodent and non-rodent, to avoid overlooking unexpected adverse effects before introducing new chemical entities into humans. While animal testing has faced controversy, alternatives using biotechnology tools such as transgenic animal models, cell cultures, and in silico methods are being developed wherever possible to reduce animal use. These alternative techniques include cell line techniques, full thickness skin models, and patch clamp methods to study ion channels at a cellular level.
The document provides an overview of the regulatory process for bringing a new drug to market, beginning with pre-clinical studies and submission of an Investigational New Drug (IND) application to the FDA. If approved, the IND allows clinical trials to be conducted in three phases to evaluate safety and efficacy. If phase 3 trials demonstrate a drug is safe and effective, a New Drug Application or Biologics License Application can be submitted for approval to market the drug. Ongoing monitoring of safety continues even after approval.
Alternative methods to animal toxicity testingpriyachhikara1
This document discusses alternative methods to animal toxicity testing, including in silico computer simulation methods, in vitro cell culture techniques, using fewer animals, microdosing, and epidemiological and clinical studies. It provides details on regulatory agencies that promote alternative testing methods, as well as specific alternative tests that have been developed and validated according to OECD guidelines to replace or reduce animal use.
This document discusses alternatives to animal testing for drug development and safety testing. It outlines 4 steps to developing and validating alternative methods: defining the alternative, developing the alternative using in vitro and computer models, validating the methods, and gaining acceptance. Recent advances in stem cells and organ-on-chip models provide more human-relevant alternatives. In vitro tests using human cells, tissues, and organ models can replace animal use for toxicity, efficacy, and disease modeling. Computer models also simulate human biology for drug screening without animals.
Alternative methods to animal toxicity testingSachin Sharma
This document presents information on alternative methods to animal toxicity testing. It discusses the need for alternatives due to the harms animals face in toxicity testing. The 3Rs principles of reduction, refinement and replacement are explained, which aim to minimize animal use and suffering. The validation process for new alternative methods through organizations like ECVAM is covered. Specific alternative methods mentioned include in vitro tests like the Ames test and HET-CAM test, in silico methods, and mathematical models. The HET-CAM test for eye irritation is described in more detail.
This document discusses several alternative methods that can be used instead of animal experiments for pharmacological and toxicological screening. It describes the full thickness skin model method which uses skin tissue to evaluate the effects of substances instead of live animals. It also mentions in silico methods which use computer programs and knowledge of similar substances to predict properties without testing. The document outlines the cell line technique using continuous cell lines to screen for effects like anticancer drugs. Finally, it explains the patch clamp technique which studies individual ion channels in isolated cells and kidney tubules as an alternative to testing on whole animals.
Alternative methods to animal testing: reviewankit sharma
Animals are used in various areas of biomedical science such as teaching, research, and testing of drugs. While animal models provide important insights, they have limitations in translating findings to humans due to interspecies differences. To reduce animal use, alternatives such as computer modeling, tissue cultures, and microdosing are being utilized. The 3Rs principle of replacement, reduction, and refinement is also applied to minimize animal pain and distress when animal use is necessary.
Assignment on Alternatives to Animal Screening MethodDeepak Kumar
Toxicity studies are generally performed to determine drug effects that cannot be evaluated through standard pharmacology profiles or that only occur with repeated administration. Most toxicity tests are performed in two species, such as a rodent and non-rodent, to avoid overlooking unexpected adverse effects before introducing new chemical entities into humans. While animal testing has faced controversy, alternatives using biotechnology tools such as transgenic animal models, cell cultures, and in silico methods are being developed wherever possible to reduce animal use. These alternative techniques include cell line techniques, full thickness skin models, and patch clamp methods to study ion channels at a cellular level.
The document provides an overview of the regulatory process for bringing a new drug to market, beginning with pre-clinical studies and submission of an Investigational New Drug (IND) application to the FDA. If approved, the IND allows clinical trials to be conducted in three phases to evaluate safety and efficacy. If phase 3 trials demonstrate a drug is safe and effective, a New Drug Application or Biologics License Application can be submitted for approval to market the drug. Ongoing monitoring of safety continues even after approval.
Alternative methods to animal toxicity testingpriyachhikara1
This document discusses alternative methods to animal toxicity testing, including in silico computer simulation methods, in vitro cell culture techniques, using fewer animals, microdosing, and epidemiological and clinical studies. It provides details on regulatory agencies that promote alternative testing methods, as well as specific alternative tests that have been developed and validated according to OECD guidelines to replace or reduce animal use.
The document discusses alternatives to animal experiments that can be used in biomedical research and testing. It covers 3R strategies like refinement, reduction and replacement of animal experiments. Some alternatives mentioned include in vitro cell and tissue culture methods, computer-based models, microdosing studies and quantitative structure-activity relationships. The summary provides an overview of the different alternative methods discussed in the document like in vitro toxicity testing, in chemico tests, computer-assisted learning programs, microfluidic chips and in silico models. The use of these alternatives can help reduce animal experiments while making toxicity testing more accurate and reliable.
These presentation includes the information about the replacement of animal experiments (invivo tests) with all the alternative methods like invitro tests and in-silico methods which are used in present century and made the research work easy for pre-clinical and clinical trials.
Reproductive toxicology studies ACCORDING TO OECD guidlines 422 SONALPANDE5
Reproductive toxicity studies are conducted according to OECD Guideline 422 to evaluate effects on fertility and development. The study involves administering graduated doses of a test chemical to male and female rats for at least 4 weeks prior to mating. Males continue dosing until sacrifice, while females are dosed throughout mating, pregnancy, and lactation until sacrifice on postnatal day 13. Offspring are observed for signs of toxicity. Clinical observations and pathology examinations are conducted to identify any reproductive or developmental effects.
1. The document discusses alternatives to animal experiments, including in vitro methods like cell and tissue culture, computer modeling, and microdosing.
2. Specific alternatives mentioned include the embryonic stem cell test, Limulus amoebocyte lysate test, organ-on-chip models, and the local lymph node assay.
3. The principles of replacement, reduction and refinement of animal experiments are also covered, along with relevant laws and the need to minimize harm to animals in research.
This document discusses screening methods for anticancer agents. It describes both in vitro and in vivo methods. For in vitro screening, assays are discussed that measure cell viability, proliferation, and cytotoxicity, such as the MTT assay, Sulforhodamine B assay, 3H-thymidine uptake assay, and dye exclusion tests. For in vivo screening, models are described that use chemically-induced tumors in animals as well as cell line and xenograft transplant models to test potential anticancer agents and measure effects on tumor growth.
Alternative methods to animals testing are the development and implementation of test method that avoid use of live animals or use of less animals in method.
The council directive on protection of animals used for experiments and scientific purpose in article 23
“The commission and member states should encourage
research into development and validation of alternative methods which could provide the same level of information as that obtained in experiment using animals but which involves less animal”.
Alternative methods able to do:
Reduce Refine Replace
collectively called as “The 3Rs Principle”.
Needs for alternative methods
Because in laboratory animals may be:
Poisoned.
Deprived of food water and sleep.
Applied with skin and eye irritants.
Subjected to psychological stress.
Deliberately infected with the infected disease.
The document discusses alternative techniques to animal testing in drug and chemical research. It defines alternatives as methods that replace, reduce, or refine animal use. Several specific alternative techniques are described, including full thickness skin models, in silico computer modeling, cell line techniques, and patch clamp electrophysiology. The techniques aim to provide comparable data to animal tests while avoiding or minimizing animal use.
This document discusses the requirements for an investigational new drug (IND) application. An IND is required to initiate clinical trials of an unapproved drug and must contain information on animal studies, manufacturing, and clinical trial protocols. The core battery of safety pharmacology studies evaluates effects on major organ systems like the cardiovascular, central nervous, and respiratory systems. These studies are designed to identify potential adverse effects and safety risks before human clinical trials.
SlideShare on Traditional drug design methods Naveen K L
1) Traditional drug design involved methods like random screening of natural products and synthetic compounds, trail-and-error testing of plant extracts, ethnopharmacology approaches studying traditional medicines, and occasional serendipitous discoveries.
2) Key events in traditional drug discovery included the identification of microorganisms in the 17th-19th centuries and Paul Ehrlich's development of chemotherapy in the early 20th century using synthetic chemicals.
3) Methods of traditional drug design included random screening, trail-and-error testing, ethnopharmacology studies of traditional medicines, serendipitous discoveries, and classical pharmacology measuring biological responses. Many important drugs like artemisinin, digoxin,
Animal studies have several limitations for predicting human outcomes, including interspecies differences in disease susceptibility, pharmacokinetics, and responses to stress. Studies in stressful laboratory environments and using chronic high doses can distort results. Alternatives to animal testing are needed and should incorporate the principles of reduction, replacement, and refinement. These include addressing methodological issues in animal experiments like small sample sizes, lack of randomization and blinding, and conflicts of interest. The external validity of animal models is reduced due to differences between young, healthy research animals and elderly, comorbid human patients.
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxashharnomani
This document provides guidance on the characterization of test items used in regulatory toxicology studies according to OECD GLP principles. It defines key terms like test item, batch, vehicle, and formulation. It describes the importance of characterizing test items to confirm their identity and suitability for studies. Guidance is provided on characterizing specific types of test items like those in early development, living organisms, medical devices, and radiolabeled items. The characterization should include information on the test item's source, composition, and relevant properties.
This document discusses techniques for in silico lead discovery in drug development. It describes identifying a target and bioassay, finding a lead compound, isolating and purifying the compound, determining its structure, studying structure-activity relationships, and identifying the pharmacophore. Methods for identifying lead compounds include random screening, non-random screening, high-throughput screening, and structure-based drug design. After preclinical studies, compounds undergo clinical trials in four phases before potential release as an approved drug.
The document discusses the Investigational New Drug (IND) application process with the FDA. An IND application allows a company to ship an experimental drug across state lines and begin clinical trials. It must include preclinical data to show the drug is safe for initial human use as well as protocols for proposed studies. The FDA reviews the IND for 30 days before clinical trials may begin to ensure subject safety. The overall goal of an IND is to facilitate testing of new drugs while protecting clinical trial participants.
This document discusses various methods for pharmacological and toxicological screening of substances. It provides details on:
- Types of toxicity testing including acute, sub-acute, sub-chronic, and chronic toxicity tests.
- Methods for determining lethal dose 50 (LD50) and lethal concentration 50 (LC50) values which represent doses/concentrations that are lethal to 50% of test subjects.
- Specific acute oral toxicity testing methods like Karber's method, Miller-Tainter method, and up-and-down method.
- Testing procedures which involve administering graduated doses of a test substance to rodents and making observations to determine health hazards.
The document discusses alternatives to animal testing that can provide more accurate and humane methods for toxicity testing and medical research. Some key alternatives mentioned include cell cultures grown from human tissues, microdosing studies conducted on human volunteers, computer simulations, and organ-on-chip models containing living human cells. While alternatives reduce animal use, the document notes they cannot fully replace whole-body testing in animals, which is still needed to determine drug safety and efficacy for approval. The goal is to continue advancing alternative methods to refine, reduce and replace animal experiments wherever possible.
Preclinical screening of new substance for pharmacological activityShrutiGautam18
1) The document summarizes various preclinical screening methods used to evaluate potential new substances for pharmacological activity, including methods to test for CNS stimulants, antidepressants, and antipsychotics.
2) Common screening methods described are photoactometer testing for analeptics, runway and treadwheel tests for locomotor activity, and rotarod and barbiturate-induced sleep tests for motor coordination.
3) Tests for antidepressants include water wheel, learned helplessness, and tail suspension tests, while antipsychotic screening involves golden hamster aggression tests and measuring catalepsy in rodents.
Screening Tests for Toxic Chemicals: An OverviewJoseph Holson
This document provides an overview of screening tests for toxic chemicals. It defines screens as simplified tests designed to identify agents requiring further evaluation or exclude them from further testing. Key purposes of screens include economic savings, increased speed and number of chemicals evaluated while decreasing animal use. Screens must be valid, sensitive, reproducible and practical. The document discusses criteria for validation and acceptance of new testing methods and provides examples of in vitro and in vivo screens used in toxicology. It also discusses how screens fit within the regulatory testing structure and notes some limitations of screens in fully characterizing toxicity.
2016 Dal Human Genetics - Genomics in Medicine LectureDan Gaston
Genomic medicine aims to identify genetic variations that cause disease and inform treatment. While whole genome sequencing is technically possible for $1000, analysis costs remain high. Current clinical applications include diagnosing rare childhood disorders and guiding cancer treatment. Continued cost reductions and expanding biological knowledge databases will drive further innovation, though challenges around data interpretation and reporting remain. Large reference populations and functional studies are still needed to realize genomics' full potential in healthcare.
The document discusses alternatives to animal experiments that can be used in biomedical research and testing. It covers 3R strategies like refinement, reduction and replacement of animal experiments. Some alternatives mentioned include in vitro cell and tissue culture methods, computer-based models, microdosing studies and quantitative structure-activity relationships. The summary provides an overview of the different alternative methods discussed in the document like in vitro toxicity testing, in chemico tests, computer-assisted learning programs, microfluidic chips and in silico models. The use of these alternatives can help reduce animal experiments while making toxicity testing more accurate and reliable.
These presentation includes the information about the replacement of animal experiments (invivo tests) with all the alternative methods like invitro tests and in-silico methods which are used in present century and made the research work easy for pre-clinical and clinical trials.
Reproductive toxicology studies ACCORDING TO OECD guidlines 422 SONALPANDE5
Reproductive toxicity studies are conducted according to OECD Guideline 422 to evaluate effects on fertility and development. The study involves administering graduated doses of a test chemical to male and female rats for at least 4 weeks prior to mating. Males continue dosing until sacrifice, while females are dosed throughout mating, pregnancy, and lactation until sacrifice on postnatal day 13. Offspring are observed for signs of toxicity. Clinical observations and pathology examinations are conducted to identify any reproductive or developmental effects.
1. The document discusses alternatives to animal experiments, including in vitro methods like cell and tissue culture, computer modeling, and microdosing.
2. Specific alternatives mentioned include the embryonic stem cell test, Limulus amoebocyte lysate test, organ-on-chip models, and the local lymph node assay.
3. The principles of replacement, reduction and refinement of animal experiments are also covered, along with relevant laws and the need to minimize harm to animals in research.
This document discusses screening methods for anticancer agents. It describes both in vitro and in vivo methods. For in vitro screening, assays are discussed that measure cell viability, proliferation, and cytotoxicity, such as the MTT assay, Sulforhodamine B assay, 3H-thymidine uptake assay, and dye exclusion tests. For in vivo screening, models are described that use chemically-induced tumors in animals as well as cell line and xenograft transplant models to test potential anticancer agents and measure effects on tumor growth.
Alternative methods to animals testing are the development and implementation of test method that avoid use of live animals or use of less animals in method.
The council directive on protection of animals used for experiments and scientific purpose in article 23
“The commission and member states should encourage
research into development and validation of alternative methods which could provide the same level of information as that obtained in experiment using animals but which involves less animal”.
Alternative methods able to do:
Reduce Refine Replace
collectively called as “The 3Rs Principle”.
Needs for alternative methods
Because in laboratory animals may be:
Poisoned.
Deprived of food water and sleep.
Applied with skin and eye irritants.
Subjected to psychological stress.
Deliberately infected with the infected disease.
The document discusses alternative techniques to animal testing in drug and chemical research. It defines alternatives as methods that replace, reduce, or refine animal use. Several specific alternative techniques are described, including full thickness skin models, in silico computer modeling, cell line techniques, and patch clamp electrophysiology. The techniques aim to provide comparable data to animal tests while avoiding or minimizing animal use.
This document discusses the requirements for an investigational new drug (IND) application. An IND is required to initiate clinical trials of an unapproved drug and must contain information on animal studies, manufacturing, and clinical trial protocols. The core battery of safety pharmacology studies evaluates effects on major organ systems like the cardiovascular, central nervous, and respiratory systems. These studies are designed to identify potential adverse effects and safety risks before human clinical trials.
SlideShare on Traditional drug design methods Naveen K L
1) Traditional drug design involved methods like random screening of natural products and synthetic compounds, trail-and-error testing of plant extracts, ethnopharmacology approaches studying traditional medicines, and occasional serendipitous discoveries.
2) Key events in traditional drug discovery included the identification of microorganisms in the 17th-19th centuries and Paul Ehrlich's development of chemotherapy in the early 20th century using synthetic chemicals.
3) Methods of traditional drug design included random screening, trail-and-error testing, ethnopharmacology studies of traditional medicines, serendipitous discoveries, and classical pharmacology measuring biological responses. Many important drugs like artemisinin, digoxin,
Animal studies have several limitations for predicting human outcomes, including interspecies differences in disease susceptibility, pharmacokinetics, and responses to stress. Studies in stressful laboratory environments and using chronic high doses can distort results. Alternatives to animal testing are needed and should incorporate the principles of reduction, replacement, and refinement. These include addressing methodological issues in animal experiments like small sample sizes, lack of randomization and blinding, and conflicts of interest. The external validity of animal models is reduced due to differences between young, healthy research animals and elderly, comorbid human patients.
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxashharnomani
This document provides guidance on the characterization of test items used in regulatory toxicology studies according to OECD GLP principles. It defines key terms like test item, batch, vehicle, and formulation. It describes the importance of characterizing test items to confirm their identity and suitability for studies. Guidance is provided on characterizing specific types of test items like those in early development, living organisms, medical devices, and radiolabeled items. The characterization should include information on the test item's source, composition, and relevant properties.
This document discusses techniques for in silico lead discovery in drug development. It describes identifying a target and bioassay, finding a lead compound, isolating and purifying the compound, determining its structure, studying structure-activity relationships, and identifying the pharmacophore. Methods for identifying lead compounds include random screening, non-random screening, high-throughput screening, and structure-based drug design. After preclinical studies, compounds undergo clinical trials in four phases before potential release as an approved drug.
The document discusses the Investigational New Drug (IND) application process with the FDA. An IND application allows a company to ship an experimental drug across state lines and begin clinical trials. It must include preclinical data to show the drug is safe for initial human use as well as protocols for proposed studies. The FDA reviews the IND for 30 days before clinical trials may begin to ensure subject safety. The overall goal of an IND is to facilitate testing of new drugs while protecting clinical trial participants.
This document discusses various methods for pharmacological and toxicological screening of substances. It provides details on:
- Types of toxicity testing including acute, sub-acute, sub-chronic, and chronic toxicity tests.
- Methods for determining lethal dose 50 (LD50) and lethal concentration 50 (LC50) values which represent doses/concentrations that are lethal to 50% of test subjects.
- Specific acute oral toxicity testing methods like Karber's method, Miller-Tainter method, and up-and-down method.
- Testing procedures which involve administering graduated doses of a test substance to rodents and making observations to determine health hazards.
The document discusses alternatives to animal testing that can provide more accurate and humane methods for toxicity testing and medical research. Some key alternatives mentioned include cell cultures grown from human tissues, microdosing studies conducted on human volunteers, computer simulations, and organ-on-chip models containing living human cells. While alternatives reduce animal use, the document notes they cannot fully replace whole-body testing in animals, which is still needed to determine drug safety and efficacy for approval. The goal is to continue advancing alternative methods to refine, reduce and replace animal experiments wherever possible.
Preclinical screening of new substance for pharmacological activityShrutiGautam18
1) The document summarizes various preclinical screening methods used to evaluate potential new substances for pharmacological activity, including methods to test for CNS stimulants, antidepressants, and antipsychotics.
2) Common screening methods described are photoactometer testing for analeptics, runway and treadwheel tests for locomotor activity, and rotarod and barbiturate-induced sleep tests for motor coordination.
3) Tests for antidepressants include water wheel, learned helplessness, and tail suspension tests, while antipsychotic screening involves golden hamster aggression tests and measuring catalepsy in rodents.
Screening Tests for Toxic Chemicals: An OverviewJoseph Holson
This document provides an overview of screening tests for toxic chemicals. It defines screens as simplified tests designed to identify agents requiring further evaluation or exclude them from further testing. Key purposes of screens include economic savings, increased speed and number of chemicals evaluated while decreasing animal use. Screens must be valid, sensitive, reproducible and practical. The document discusses criteria for validation and acceptance of new testing methods and provides examples of in vitro and in vivo screens used in toxicology. It also discusses how screens fit within the regulatory testing structure and notes some limitations of screens in fully characterizing toxicity.
2016 Dal Human Genetics - Genomics in Medicine LectureDan Gaston
Genomic medicine aims to identify genetic variations that cause disease and inform treatment. While whole genome sequencing is technically possible for $1000, analysis costs remain high. Current clinical applications include diagnosing rare childhood disorders and guiding cancer treatment. Continued cost reductions and expanding biological knowledge databases will drive further innovation, though challenges around data interpretation and reporting remain. Large reference populations and functional studies are still needed to realize genomics' full potential in healthcare.
Almac is a global pharmaceutical and biotech solutions company that employs over 4,000 staff across locations in Europe, the US, and Asia Pacific. It offers over 50 career fields including quality, project management, operations, scientific research and development, software engineering, and business development. Employees benefit from competitive salaries, opportunities for growth, and initiatives that support work-life balance such as flexible working options, paid family leave, health benefits, and recognition programs. Almac is committed to hiring, developing, and retaining top talent to advance human health through superior drug development solutions.
148320592002 SWOT Analysis Of new pharmaceutical CompaniesDharmik Bhatt
The document is a summer project presentation submitted by Dharmik Bhatt on conducting a SWOT analysis of a new pharmaceutical company. It includes an overview of the pharmaceutical industry in India and the company being analyzed, WellCare LifeScience. It outlines the literature review, problem statement, research topic, objectives, and methodology. The methodology section describes using a sample of 60 doctors and 40 retailers/wholesalers in Vadodara, collecting primary data through structured surveys and personal interviews. The data analysis sections summarize the results of the doctor and retailer/wholesaler surveys, finding that over half of doctors are open to prescribing new company products if they are economical and high quality, and retailers are interested in working with new companies
Almac is a global pharmaceutical and biotech solutions company that employs over 4,000 staff across facilities in Europe, the US, and Asia Pacific. It offers over 50 career fields including quality, project management, operations, scientific research and development, software engineering, and business development. Employees receive competitive salaries, opportunities for growth, and benefits such as health insurance, retirement plans, flexible work schedules, and professional development programs. Almac is committed to hiring and retaining top talent to help advance new life-saving drugs.
This document summarizes new architectural products featured in 2015 from European manufacturers Olivari, Bonaiti, FritsJurgens, and CEAM. It discusses concealed door hinges and pivots from FritsJurgens that are fully embedded in doors and have no floor plates. It also describes magnetic door latches from Bonaiti that have no visible striker plates or protruding parts. Handles from Olivari are described that have durable finishes resistant to corrosion. Glass door hinges from CEAM allow adjustment of door positions and quick removal of doors.
Strathmore University - Leading Private Non-Profit University in East Africa,Linda Makong'o
This document contains tweets from the Twitter account of Strathmore University, a private non-profit university located in Kenya. The tweets promote opportunities at Kuona Trust for an intern and wish the university's Vice Chancellor well. They are interspersed with promotional messages from an advertising partner.
This short document promotes the creation of presentations using Haiku Deck on SlideShare. It includes a photo credit and a call to action encouraging the reader to get started making their own Haiku Deck presentation on SlideShare.
Almac is a global pharmaceutical and biotech solutions company that employs over 4,000 staff across facilities in Europe, the US, and Asia Pacific. It offers over 50 career fields including quality, project management, operations, scientific research and development, software engineering, and business development. Employees receive competitive salaries, opportunities for growth, and benefits such as health insurance, retirement plans, flexible work schedules, and professional development programs. The company is committed to hiring and retaining top talent to help advance new life-saving drugs.
EGN UK is a division of Executives' Global Network, which provides peer-based networking services through over 700 confidential groups for executives. EGN aims to support over 42,000 members across 14 countries through closed peer advisory groups, knowledge sharing apps, cross-group meetings, and networking events. Members can discuss business issues, develop skills and knowledge, and support one another's careers and initiatives in a confidential setting. EGN ensures new members have no conflicts of interest with existing members and provides ongoing support through group chairs and check-ins.
Ravula Venkateswarlu has over 6 years of experience managing clinical trial supply chains as a senior pharmacist assistant at World Courier in Bangalore, India. He has supervised teams and protocols involving over 150 clinical trials. His experience includes activities such as protocol management, inventory management, packaging and labeling, distribution, cold chain management, and reconciliation of returned medications. He has a Master's degree in Marine Biology and certifications in GMP, GCP, and cold chain management.
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.comNeelima Sharma
The document provides an overview of the drug discovery process, including the need for new drugs, approaches to discovery, and changes over time. It discusses target identification, validation, lead identification, optimization, and preclinical pharmacology/toxicology. The phases of clinical trials are also summarized, including Phase I safety trials in healthy volunteers, Phase II therapeutic exploration trials, and large Phase III randomized controlled trials. The roles of various parties in clinical trials are also outlined.
4 4 condiciones para una evaluacion orientadaCarlos Lopez
Este documento discute la importancia de una evaluación orientada al aprendizaje en la educación superior. Explica que la evaluación debe involucrar tareas que impliquen a los estudiantes en el aprendizaje, proporcionar retroalimentación para mejorar, y permitir que los estudiantes evalúen su propio trabajo. También analiza diferentes técnicas de evaluación como observaciones, portafolios y exámenes, y cómo pueden usarse para promover el aprendizaje. El documento concluye que los cambios en la evaluación son necesarios para aline
3D In Vitro Models for Drug Efficiency TestingTiffany Ho
3D cell cultures more accurately model the in vivo microenvironment compared to traditional 2D cultures. 3D cultures form cell aggregates or spheroids, mimic tumor development, and allow for more effective drug testing compared to flat monolayers. Emerging technologies like organ-on-chip microfluidic devices and 3D printing have the potential to further advance 3D cell culture models by replicating the functions of human organs and embedding living cells in scaffolds.
This document discusses various aspects of dermatotoxicity testing including skin structure and function, dermatotoxic reactions, OECD testing guidelines, and specific dermatotoxicity tests. It summarizes common dermatotoxicity tests including acute dermal toxicity tests, repeated dose dermal toxicity tests lasting 21-28 days, subchronic dermal toxicity tests lasting 90 days, and in vitro tests for skin corrosion. Testing procedures, observations, data collection, and reporting requirements are outlined for each test.
Walmart has developed an efficient supply chain management system that has allowed it to become the largest retailer in the world. It uses a hub and spoke distribution model with cross-docking to reduce inventory costs. Walmart invests heavily in technology like RFID and voice-order filling to streamline operations and inventory tracking. Strong communication networks allow it to collaborate closely with suppliers on forecasting and replenishment. These integrated systems and large purchasing volumes provide Walmart with competitive advantages in price and availability.
Alternate animal experiments models for pre and post clinical screening of new drugs.
#Expetrimental_Pharmacology.
#Preclinical Screening methods and testing models.
#Animal_Handeling
This document discusses the history and types of animal experimentation. It notes that Aristotle and Erasistratus were among the first to use living animals in experiments. It outlines the types of animal research including basic research, applied research, toxicology testing, and xenotransplantation. Common animal models used are rats, mice, rabbits, and guinea pigs. The document also discusses the principles of replacement, reduction and refinement of animal experiments and the ethical requirements for conducting such research.
Chapter 2- research involving animals .pptxHendmaarof
Researchers use animal models in research to understand human physiology, diseases, and develop new treatments. Animals are used because they share many biological similarities to humans despite differences in appearance. The 3Rs principles of replacement, reduction, and refinement guide researchers to replace animal use when possible, reduce the number of animals used, and refine experiments to minimize animal suffering. While some disagree with animal research, proponents argue it has advanced medical knowledge and led to treatments for conditions like polio, cystic fibrosis, and stroke.
The document discusses animal testing and some of the ethical issues surrounding it. It notes that while controversial, animal research has allowed medical and scientific advances. Around 50-100 million animals are used in research each year. The document explores how pain and suffering in animal testing is measured, and outlines some of the arguments made by proponents and opponents of animal testing. It also discusses alternatives to animal testing such as the three R's of replacement, reduction and refinement.
Non-human primates in research and safety testingGreenFacts
Every year, more than 100 000 monkeys and apes are used for biomedical research around the world. Their genetic similarities to humans make them particularly suitable candidates for testing the safety of new drugs and for studying infectious diseases or the brain. But those very similarities to humans also raise specific ethical questions about their use for scientific experiments.
Are there alternatives to the use of non-human primates in research and testing? Would it be feasible to stop using them altogether?
Animal testing is commonly used in scientific research and development. It helps ensure product safety and advance medical research. However, it raises ethical issues and alternatives are being developed. Reduction methods aim to minimize the number of animals used through better study design and data sharing. Refinement improves animal welfare. Replacement seeks to avoid animal use by developing alternative methods like computer modeling, microfluidics, and serum-free cell cultures. As technology advances, more research can be done without harming animals.
Alternatives to animal studies in Pharmaceutical research has been explained on the basis of replacement, reduction and refinement. Also newer pre-clinical animal models like use of genetically modified animals were presented.
The document provides an overview of guinea pigs as an experimental animal model. It discusses the scientific name and taxonomy of guinea pigs, introduces them as a domesticated rodent species originally from South America. It describes their physical appearance including size, weight, litter size and lifespan. It outlines the different species of guinea pigs and their descriptions. The document discusses guinea pigs' use in drug assays and routes of administration, their physiological and hematological parameters. It notes pros and cons of using guinea pigs as well as their applications in various disease studies. In conclusion, it states why guinea pigs are a preferred experimental model.
Physiology means study of functions. It is a subject that include everything about how organisms work and how they coordinate within their own bodies and also how they respond to the ever-changing environment.
Welcome to the wonderful world of physiology.
Advancing Animal Welfare Standards within the Veterinary ProfessionAndrew Knight
Veterinarians are widely considered to be experts on animal welfare. However, our survey of the positions of five of the world’s leading veterinary associations on five important animal use practices revealed that their positions frequently lagged behind those of the general public. These practices were the close confinement of laying hens in ‘battery cages,’ of pregnant sows in gestation crates, of veal calves in small crates, the cosmetic tail-docking of dogs, and the use of animals in scientific research and education.
To further examine the attitudes of veterinarians towards animal welfare, we ascertained the positions of the American Veterinary Medical Association (AVMA) on a broad range of practices commonly considered to result in poor welfare. With a veterinary membership in excess of 72,000 by 2005—the largest of any veterinary association—and claiming to act as “a collective voice for its membership and for the profession,” the AVMA is ideally suited to this purpose. While the AVMA did not support all practices resulting in poor welfare, it did support a substantial number of them, in some cases contrary to strong scientific evidence.
Such poor positions of veterinarians on animal welfare issues are largely attributable to deficiencies in veterinary education. Although humane alternatives are being introduced, harmful animal use in surgical and preclinical training remains common in veterinary courses worldwide, and although animal welfare and bioethics courses are also being introduced, these remain minimal in most veterinary curricula. Additional causes may include deficiencies in the selection of veterinary students, and misrepresentation of the opinions of veterinarians by their professional associations.
Solutions could include consideration of animal welfare awareness and critical reasoning ability during the selection of veterinary students, increased bioethics and critical reasoning training during veterinary education, continuing education credits for veterinarians who participate in such post-graduate training, the replacement of remaining harmful animal use in veterinary education with humane alternatives, and the encouragement of more active involvement of veterinarians in their professional associations.
Medical research using animals has a long history dating back to Louis Pasteur and Ivan Pavlov in the late 19th century. Common animals used in medical research include mice, rats, dogs, cats, and primates due to their genetic and physiological similarities to humans. While controversial, animal research has led to major medical advances such as the polio vaccine and insulin. Guidelines aim to reduce animal usage and minimize suffering through the Three Rs principles.
Like all technologies, biotechnology offers the potential of enormous benefit but also potential risks. Biotechnology could help address many global problems, such as climate change, an aging society, food security, energy security and infectious diseases, to name just a few.human health and animal health and welfare and increasing livestock productivity. Biotechnology improves the food we eat - meat, milk and eggs. Biotechnology can improve an animal's impact on the environment. And biotechnology enhances ability to detect, treat and prevent diseases.
Slides for discussing concepts from the book Made to Stick by Dan and Chip Heath. Some of these slides were used for humans+the environment, Fall 2012 and the Urban Ecology Institute 2012 Summer Institute.
Animal Experimentation for Cosmetics - Resources for Healthy Children www.scribd.com/doc/254613619 - For more information, Please see Organic Edible Schoolyards & Gardening with Children www.scribd.com/doc/254613963 - Gardening with Volcanic Rock Dust www.scribd.com/doc/254613846 - Double Food Production from your School Garden with Organic Tech www.scribd.com/doc/254613765 - Free School Gardening Art Posters www.scribd.com/doc/254613694 - Increase Food Production with Companion Planting in your School Garden www.scribd.com/doc/254609890 - Healthy Foods Dramatically Improves Student Academic Success www.scribd.com/doc/254613619 - City Chickens for your Organic School Garden www.scribd.com/doc/254613553 - Huerto Ecológico, Tecnologías Sostenibles, Agricultura Organica www.scribd.com/doc/254613494 - Simple Square Foot Gardening for Schools - Teacher Guide www.scribd.com/doc/254613410 - Free Organic Gardening Publications www.scribd.com/doc/254609890 ~
Mr. Rakesh Sharma. M, M.Sc., in Applied Microbiology, Research Assistant with seven years of experience in Central Inter- Disciplinary Research Facility (CIDRF), SBV - Puducherry has joined as Research Associate in Mahatma Gandhi Medical Preclinical Research Centre (MGMPRC). A talk by him on “Zebrafish as an animal model for biomedical research” is scheduled on 19th November, 2022 (Saturday) at 2.30 pm in A1 conference hall, 1st floor Hospital block, MGMCRI.”
Animal models are living non-human animals used in research to better understand diseases without risking harm to humans. The document discusses various types of animal models including experimental models which mimic human diseases, spontaneous animal diseases comparable to humans, and genetically modified models. It also covers animal research standards and guidelines including housing, veterinary care, anesthesia, and humane euthanasia practices. Animal models have contributed significantly to advances in various disease treatments and public health issues.
Alternative to Animal Experiment ModelsDr Jayant Rai
The document discusses alternatives to animal experimentation. It provides an overview of animal experimentation, including its historical use and current regulatory guidelines. Some key uses of animals in experimentation include education, research, cosmetic testing, and toxicology testing. The document then discusses the development of alternatives such as in vitro techniques like cell cultures, microorganism studies, computer simulations, and epidemiological research that can replace or reduce animal use. It provides examples of specific alternative tests and methods that have been validated including embryonic stem cell tests, the Ames test, and skin patch tests. Overall, the document promotes developing and validating alternative methods to animal testing that satisfy the principles of replacement, reduction and refinement of animal use.
Microbiology is the study of microorganisms that are too small to be seen without magnification. There are several major groups of microorganisms including bacteria, algae, protozoa, fungi, and viruses. Microbiology has many branches and applications such as biotechnology, public health, food science, and more. Microorganisms were some of the earliest life on Earth and have profoundly shaped the planet through processes like photosynthesis and nutrient recycling. Humans have utilized microbes for thousands of years in applications like brewing and bread making, and more recently in biotechnology and bioremediation. Infectious microbes are also the cause of many human diseases. Taxonomy involves naming, classifying, and identifying
Similar to s.s.c (Alternative to animal study) (18)
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
1. 11
ALTERNATIVE TOALTERNATIVE TO
ANIMAL STUDYANIMAL STUDY
Presented by:- S.S.CPresented by:- S.S.C
M.Pharm (1M.Pharm (1stst
Sem.)Sem.)
Department of PharmacologyDepartment of Pharmacology
R. C. Patel College of Pharmacy, Shirpur.R. C. Patel College of Pharmacy, Shirpur.
2. 22
Main Points to be CoveredMain Points to be Covered
HistoryHistory
Concept of AlternativeConcept of Alternative
EthicsEthics
Uses of 3R and alternativeUses of 3R and alternative
Globalization of R- ConceptGlobalization of R- Concept
Do they work?Do they work?
OrganizationOrganization
3. 33
HistoryHistory (1,2)(1,2)
Galen, a physician in second-century Rome dissected pigs andGalen, a physician in second-century Rome dissected pigs and
goats, and is known as the "goats, and is known as the "father of vivisectionfather of vivisection""
1880- Louis Pasteur convincingly demonstrated the germ1880- Louis Pasteur convincingly demonstrated the germ
theory of medicine by giving anthrax to sheep.theory of medicine by giving anthrax to sheep.
1890- Ivan Pavlov famously used dogs to describe classical1890- Ivan Pavlov famously used dogs to describe classical
conditioning. Insulin was first isolated from dogs in 1922conditioning. Insulin was first isolated from dogs in 1922
1957- a Russian dog became the first of many animals to orbit1957- a Russian dog became the first of many animals to orbit
the earth.the earth.
4. 44
The purpose of animal experimentsThe purpose of animal experiments (1,15,3)(1,15,3)
1.1. The use of animal testing in the development and qualityThe use of animal testing in the development and quality
control of products for human and veterinary healthcare.control of products for human and veterinary healthcare.
22 To increase our fundamental scientific knowledge.To increase our fundamental scientific knowledge.
5. 55
Facts and figures on animal experimentsFacts and figures on animal experiments (14)(14)
100 million animals are experimented every year, The100 million animals are experimented every year, The
British Union for the Abolition of Vivisection (BUAV)British Union for the Abolition of Vivisection (BUAV)
10–11 million of them in the European Union10–11 million of them in the European Union
25 million are used in USA25 million are used in USA
Council on Bioethics reports, 50 to 100 million vertebrateCouncil on Bioethics reports, 50 to 100 million vertebrate
animals used annually worldwide.animals used annually worldwide.
According to USDA's figures :-1,177,566 animals used inAccording to USDA's figures :-1,177,566 animals used in
2005.2005.
7. 77
Introduction of alternativeIntroduction of alternative (1,4,15)(1,4,15)
In 1842 British Society for theIn 1842 British Society for the
Prevention of Cruelty to AnimalsPrevention of Cruelty to Animals
In 1959 W.M.S. Russell and R.L.In 1959 W.M.S. Russell and R.L.
Burch published their book-Burch published their book-
The Principles of HumaneThe Principles of Humane
Experimental TechniqueExperimental Technique
IN 1954 :- Universities FederationIN 1954 :- Universities Federation
for Animal Welfare (UFAW) infor Animal Welfare (UFAW) in
the UK.the UK.
8. 88
Replacement:Replacement:
Methods that permit a givenMethods that permit a given
purpose to be achieved withoutpurpose to be achieved without
conduction experiments or otherconduction experiments or other
scientific procedures on vertebratescientific procedures on vertebrate
animals.animals.
Reduction:Reduction:
Methods for obtaining comparableMethods for obtaining comparable
levels of information from the uselevels of information from the use
of fewer animals in scientificof fewer animals in scientific
procedures, or for obtaining moreprocedures, or for obtaining more
information from the same numberinformation from the same number
of animals.of animals.
9. 99
Refinement:Refinement:
Methods that alleviate orMethods that alleviate or
minimise pain, suffering andminimise pain, suffering and
distress, and which enhancedistress, and which enhance
animal well-being.animal well-being.
10. 1010
Rules in India :-Rules in India :-
Prevention of Cruelty to Animal Act, 1960.Prevention of Cruelty to Animal Act, 1960.
CPCSEA Guide lines.CPCSEA Guide lines.
11. 1111
The objectives of this module areThe objectives of this module are (1,4,15)(1,4,15)
To discuss the Three Rs as they were defined by Russell andTo discuss the Three Rs as they were defined by Russell and
Burch in 1959Burch in 1959
To introduce the concept of alternatives inTo introduce the concept of alternatives in Research,Research,
Teaching and TestingTeaching and Testing..
To discuss the potentials and limitations of alternativesTo discuss the potentials and limitations of alternatives
To consider examples of alternatives and how they may beTo consider examples of alternatives and how they may be
usedused
12. 1212
Alternative MethodologiesAlternative Methodologies (15)(15)
Alternative technology :-Alternative technology :-
Economy :- timeEconomy :- time
costcost
no. of animals usedno. of animals used
Stress = DISTRESS.Stress = DISTRESS.
13. 1313
• Animal ModelsAnimal Models
• Animal Testing alternative (s)Animal Testing alternative (s)
• In vitro (method,In vitro (method,
model, technique)model, technique)
• Non-animal alternative (s)Non-animal alternative (s)
Cell CultureCell Culture
Tissue CultureTissue Culture
Organ CultureOrgan Culture
• Single-cell OrganismsSingle-cell Organisms
InvertebratesInvertebrates
• FishFish
• Simulator (s)Simulator (s)
• Mannequin (s)Mannequin (s)
• MathematicalMathematical
Model (s)Model (s)
• Computer-interfacedComputer-interfaced
InteractiveInteractive
Digital Image LibrariesDigital Image Libraries
Virtual SurgeryVirtual Surgery
Virtual RealityVirtual Reality
• ComputerComputer simulation (s)simulation (s)
Computer program (s)Computer program (s)
Computer SoftwareComputer Software
Computer Aided InstructionComputer Aided Instruction
• Physiological Simulation (s)Physiological Simulation (s)
Videodisc (s)Videodisc (s)
Video displayVideo display
Video (s)Video (s)
14. 1414
ReplacementReplacement
11.Using of living system.Using of living system
In vitro TechniquesIn vitro Techniques
Invertebrates AnimalsInvertebrates Animals
Micro-organismsMicro-organisms
2.2. Using Non-living systemsUsing Non-living systems
Chemical TechniqueChemical Technique
Physical/Mechanical SystemsPhysical/Mechanical Systems
3.3. Use of computer simulationUse of computer simulation
17. 1717
Use of living SystemsUse of living Systems
1.1. In vitro Techniques-In vitro Techniques-
Non animal living systemsNon animal living systems
There are three types:-There are three types:-
Cell culture, Tissue culture, Organ cultureCell culture, Tissue culture, Organ culture
Greatest control of test subject environment.Greatest control of test subject environment.
Eg. – SkintexEg. – Skintex
An in-vitro method to assess skin irritancy that uses pumpkinAn in-vitro method to assess skin irritancy that uses pumpkin
rind to mimic the reaction of a foreign substance on humanrind to mimic the reaction of a foreign substance on human
skin.skin.
18. 1818
EytexEytex
National Testing Corp. in Palm Springs,National Testing Corp. in Palm Springs,
Is an in-vitro (test-tube) procedure that measures eyeIs an in-vitro (test-tube) procedure that measures eye
irritancy via a protein alteration system. A vegetable proteinirritancy via a protein alteration system. A vegetable protein
from the jack bean mimics the reaction of the cornea to an alienfrom the jack bean mimics the reaction of the cornea to an alien
substance.substance.
Alternative to -Alternative to -Draize eye irritancy test.Draize eye irritancy test.
Some factors are responsible :-Some factors are responsible :-
Atmosphere HumidityAtmosphere Humidity
Temperature PTemperature PHH
NutrientsNutrients
19. 1919
Invertebrate Animals :-Invertebrate Animals :-
More commonly used laboratory animals.More commonly used laboratory animals.
90% of animals are invertebrates90% of animals are invertebrates
Example- fruit fly,Example- fruit fly, Drosophila melanogaster.Drosophila melanogaster.
Uses- Study of genetics, Mutagenicity, teratogenicity, and reproductiveUses- Study of genetics, Mutagenicity, teratogenicity, and reproductive
toxicity.toxicity.
Marine Invertebrates – are different species and used to study theMarine Invertebrates – are different species and used to study the
physiology of Nervous System.physiology of Nervous System.
21. 2121
Micro-OrganismsMicro-Organisms
Use to replace the animal modelsUse to replace the animal models
Example –Example – Ames testAmes test – used for carcinogenicity/ mutagenicity– used for carcinogenicity/ mutagenicity
–by using–by using Salmonela typhimurium.Salmonela typhimurium.
Allow limit less compounds to be tested which create anAllow limit less compounds to be tested which create an
interesting dilemmainteresting dilemma
Also used for the screening process.Also used for the screening process.
Agarose Diffusion Method.Agarose Diffusion Method.
22. 2222
Using Non-living systemsUsing Non-living systems
1.1. Chemical techniques :-Chemical techniques :-
ChromatographicChromatographic andand spectroscopicspectroscopic..
Immunochemical techniquesImmunochemical techniques use for binding capacity ofuse for binding capacity of
highly specific antibodies to seek out minute quantities ofhighly specific antibodies to seek out minute quantities of
antigenantigen
Eg.-Eg.- Technique to identify bacterial toxins -- which save severalTechnique to identify bacterial toxins -- which save several
mice.mice.
23. 2323
ELISA :-ELISA :-
Home pregnancy detectionHome pregnancy detection
Previously it done by over-Previously it done by over-
the-counter test kit.the-counter test kit.
Required no. of Rabbits.Required no. of Rabbits.
25. 2525
Use of Computer SimulationUse of Computer Simulation
Computer simulation-Computer simulation-
QSARQSAR - Identification of particular chemical structure –- Identification of particular chemical structure –
shows potential reactivity – so resulting toxicity can beshows potential reactivity – so resulting toxicity can be
determine.determine.
TOPKATTOPKAT
computer software programcomputer software program
measures toxicity, mutagenicity, carcinogenicity, andmeasures toxicity, mutagenicity, carcinogenicity, and
teratonogenicityteratonogenicity
27. 2727
ReductionReduction
The IACUC can determine experimental design was employed toThe IACUC can determine experimental design was employed to
minimize overall animal use. Methods to achieve this include:minimize overall animal use. Methods to achieve this include:
1.1. Pilot studies.Pilot studies.
2.2. Designing a study to utilize animals as their own controls.Designing a study to utilize animals as their own controls.
3.3. Gathering a maximum amount of information from each animal.Gathering a maximum amount of information from each animal.
4.4. Consulting with a statistician.Consulting with a statistician.
5.5. Minimizing variablesMinimizing variables
6.6. To ensure that experiments are not duplicated.To ensure that experiments are not duplicated.
7.7. Using the appropriate species of animal so that useful data isUsing the appropriate species of animal so that useful data is
collected.collected.
28. 2828
Animal SharingAnimal Sharing :-:-
Significantly reduce the no. of use animals.Significantly reduce the no. of use animals.
Eg.-Eg.- SurgicalSurgical approach on an animal that has been, or is to beapproach on an animal that has been, or is to be
euthanatizedeuthanatized for other purposes, or providing organs orfor other purposes, or providing organs or
tissues at the time oftissues at the time of necropsy.necropsy.
If within same institute, perform same test, the control can beIf within same institute, perform same test, the control can be
take common.take common.
29. 2929
Improved Statistical DesignImproved Statistical Design
Consulting with the statistician during the design phaseConsulting with the statistician during the design phase
A design strategies-A design strategies-
Eg.-Eg.- Group sequential testing, and Crossover designs.Group sequential testing, and Crossover designs.
Low cost statistical packages for computerLow cost statistical packages for computer
30. 3030
Phylogenetic ReductionPhylogenetic Reduction
Designed to use one of the myriad of invertebrate speciesDesigned to use one of the myriad of invertebrate species
instead of a non-human primate.instead of a non-human primate.
The animals chosen for project usage should be the leastThe animals chosen for project usage should be the least
advanced from a phylogenetic standpoint.advanced from a phylogenetic standpoint.
31. 3131
Better Quality AnimalsBetter Quality Animals
When purchasing laboratory animals-cost and quality areWhen purchasing laboratory animals-cost and quality are
usually directly correlated.usually directly correlated.
The best quality animals, in terms of genetic status.The best quality animals, in terms of genetic status.
Institutional commitment of institute.Institutional commitment of institute.
Animals of different or unknown health status should neverAnimals of different or unknown health status should never
share the same.share the same.
33. 3333
RefinementRefinement
1.1. Identifying pain and distress and making plans for reliving it.Identifying pain and distress and making plans for reliving it.
2.2. Setting the earliest possible endpoint for the experiment.Setting the earliest possible endpoint for the experiment.
3.3. Receiving adequate training prior to performing a procedure.Receiving adequate training prior to performing a procedure.
4.4. Using proper handling techniques for animals.Using proper handling techniques for animals.
5.5. Ensuring that drug doses are correct and are not expired.Ensuring that drug doses are correct and are not expired.
6.6. Ensuring that procedures to be performed on the animal areEnsuring that procedures to be performed on the animal are
reasonable for that species.reasonable for that species.
7.7. Performing surgeries and procedures aseptically to preventPerforming surgeries and procedures aseptically to prevent
infection.infection.
34. 3434
8.8. Using appropriate analgesics and anesthetics for potentially painfulUsing appropriate analgesics and anesthetics for potentially painful
procedures.procedures.
9.9. Performing only a single major survival surgery on any one animal,Performing only a single major survival surgery on any one animal,
whenever possible.whenever possible.
10.10. Performing appropriate post-surgical care, including thermoregulationPerforming appropriate post-surgical care, including thermoregulation
and fluid balance.and fluid balance.
11.11. There are several specific research techniques in common use that areThere are several specific research techniques in common use that are
often criticized for their potential for causing pain or distress tooften criticized for their potential for causing pain or distress to
animals.animals.
35. 3535
Decreased InvasivenessDecreased Invasiveness
The use ofThe use of Magnetic Resonance Imaging-Magnetic Resonance Imaging- formerly requiredformerly required
euthanasia of multiple animals along a time curve to obtaineuthanasia of multiple animals along a time curve to obtain
assay tissue.assay tissue.
One animal can provide all the information along a givenOne animal can provide all the information along a given
curve-curve- Vascular Access DeviceVascular Access Device - repeated samples or- repeated samples or
injections in a single animal instead of using several animals.injections in a single animal instead of using several animals.
36. 3636
Improved InstrumentationImproved Instrumentation
Monitoring AnimalsMonitoring Animals ––
Microelectronics, fiber optics and laser instrumentation, theMicroelectronics, fiber optics and laser instrumentation, the
potential for refining techniques.potential for refining techniques.
Improved instrumentation - reducing the level of restraint and/orImproved instrumentation - reducing the level of restraint and/or
manipulation necessary to obtain biological samples.manipulation necessary to obtain biological samples.
The use of tethers in a variety of species to allow continuousThe use of tethers in a variety of species to allow continuous
access to the various organ systems.access to the various organ systems.
Advantages -Advantages - minimizing a variety of non experimentalminimizing a variety of non experimental
variables associated with prolonged restraint.variables associated with prolonged restraint.
37. 3737
Analyzing Samples –Analyzing Samples –
The available diagnostic laboratory equipment which requireThe available diagnostic laboratory equipment which require
only micro liter blood samples to perform a variety ofonly micro liter blood samples to perform a variety of
diagnostic tests.diagnostic tests.
The use of smaller sample sizes permits the use of smallerThe use of smaller sample sizes permits the use of smaller
animal species and prevents the need to euthanatize many ofanimal species and prevents the need to euthanatize many of
these species to obtain the necessary volume of bloodthese species to obtain the necessary volume of blood
It is now possible to obtain serial blood samples from smallIt is now possible to obtain serial blood samples from small
laboratory rodents which reduces the number of animals.laboratory rodents which reduces the number of animals.
38. 3838
Improved Control of PainImproved Control of Pain
The Animal Welfare Act requires -"that the principalThe Animal Welfare Act requires -"that the principal
investigator consider alternatives to any procedure likely toinvestigator consider alternatives to any procedure likely to
produce pain or distress in an experimental animal.“produce pain or distress in an experimental animal.“
Use of tranquilizers, analgesics and anesthetics.Use of tranquilizers, analgesics and anesthetics.
39. 3939
Improved Control of TechniquesImproved Control of Techniques
The handling and restraint of animalsThe handling and restraint of animals
Animals can be trained or conditioned to accept a variety ofAnimals can be trained or conditioned to accept a variety of
procedures.procedures.
It's inexpensive, readily portable, safe even at the highestIt's inexpensive, readily portable, safe even at the highest
doses and spreads rapidly through the staff.doses and spreads rapidly through the staff.
This can be the veterinarian, a member of the animal care staffThis can be the veterinarian, a member of the animal care staff
or a fellow investigator.or a fellow investigator.
40. 4040
Globalization of R- conceptGlobalization of R- concept (6,7)(6,7)
Dr. David B. MortonDr. David B. Morton, expanded this concept to the, expanded this concept to the FifteenFifteen
R'sR's :-:-
1.1. ReduceReduce the number used.the number used.
2.2. RefineRefine end points and procedures.end points and procedures.
3.3. ReplaceReplace withwith in vitro, ex vitroin vitro, ex vitro methods when possible.methods when possible.
41. 4141
44 RespectRespect all animals regardless of speciesall animals regardless of species..
55 RecognizeRecognize any adverse effects.any adverse effects.
66 RelieveRelieve pain with analgesics, distress with anxiolytics.pain with analgesics, distress with anxiolytics.
77 RefuseRefuse to carry out some procedures if concerned.to carry out some procedures if concerned.
88 ReconsiderReconsider protocol if unsure.protocol if unsure.
99 ReadRead about the science and the ethical issues.about the science and the ethical issues.
1010 ReflectReflect on the work you have carried out.on the work you have carried out.
1111 ReasonReason out why you are doing the researchout why you are doing the research
1212 RecordRecord all your observations carefully.all your observations carefully.
1313 RewardReward rather than cause harm and for happiness.rather than cause harm and for happiness.
1414 ReappraiseReappraise techniques for efficacy.techniques for efficacy.
1515 ResolveResolve to learn new techniquesto learn new techniques..
42. 4242
Search StrategySearch Strategy (8, 14,15)(8, 14,15)
Have a clear understanding of the objectives and methods ofHave a clear understanding of the objectives and methods of
the proposed studythe proposed study
Choose appropriate databases based upon the protocol.Choose appropriate databases based upon the protocol.
Develop the literature search strategy.Develop the literature search strategy.
Execute the search.Execute the search.
43. 4343
Communication between the investigator and theCommunication between the investigator and the
information specialist -information specialist -
1.1. General area of study.General area of study.
2.2. Species.Species.
3.3. Briefly describe your experimental protocol.Briefly describe your experimental protocol.
4.4. Specific systems or parts of the anatomy are involved.Specific systems or parts of the anatomy are involved.
5.5. Give correct spellings of these structures and any acronyms.Give correct spellings of these structures and any acronyms.
6.6. If you are studying the effects of a particular hormone,If you are studying the effects of a particular hormone,
enzyme, or chemical agent, give the complete spelling of theenzyme, or chemical agent, give the complete spelling of the
compound as well as its trade name and acronym.compound as well as its trade name and acronym.
7.7. Do you know of any prominent authors in your area ofDo you know of any prominent authors in your area of
research?research?
8.8. Have you published any previous literature that relates toHave you published any previous literature that relates to
your current study?your current study?
9.9. What makes your study unique from previous studies?What makes your study unique from previous studies?
46. 4646
AGRICOLA –AGRICOLA –
Covers every major agricultural subject, including agriculturalCovers every major agricultural subject, including agricultural
engineering and marketing, animal breeding, entomology,engineering and marketing, animal breeding, entomology,
environmental pollution, etc.environmental pollution, etc.
AGRICOLA Thesaurus for Animal Use AlternativesAGRICOLA Thesaurus for Animal Use Alternatives
ALTBIBALTBIB ––
Is to assist in identifying methods and procedures helpful inIs to assist in identifying methods and procedures helpful in
supporting the development, testing, application, andsupporting the development, testing, application, and
validation of alternatives to the use of vertebrates invalidation of alternatives to the use of vertebrates in
biomedical research and toxicology testing.biomedical research and toxicology testing.
Biological AbstractsBiological Abstracts ––
Worldwide journal literature in the life sciences includingWorldwide journal literature in the life sciences including
biochemistry, biophysics, experimental medicine, veterinarybiochemistry, biophysics, experimental medicine, veterinary
science, virology, and other topics.science, virology, and other topics.
47. 4747
EMBASE –EMBASE –
A large biomedical and pharmaceutical database withA large biomedical and pharmaceutical database with
extensive international coverage of drug research,extensive international coverage of drug research,
pharmacology, toxicology, environmental health, clinical andpharmacology, toxicology, environmental health, clinical and
experimental human medicine, and other topics.experimental human medicine, and other topics.
PsycINFO –PsycINFO –
Worldwide literature in psychology and related disciplines.Worldwide literature in psychology and related disciplines.
Includes research on experimental human and animalIncludes research on experimental human and animal
psychology, physiological psychology, and behavioralpsychology, physiological psychology, and behavioral
research.research.
Information on Alternatives Databases –Information on Alternatives Databases –
Produced by the Norwegian Reference Centre for LaboratoryProduced by the Norwegian Reference Centre for Laboratory
Animal Science and Alternatives. Describes databasesAnimal Science and Alternatives. Describes databases
addressing all aspects of Replacement, Reduction, andaddressing all aspects of Replacement, Reduction, and
Refinement of animal experiments.Refinement of animal experiments.
48. 4848
Altweb –Altweb –
material and news about all aspects of alternatives in animalmaterial and news about all aspects of alternatives in animal
research.. Current Research Information System (CRIS) Listsresearch.. Current Research Information System (CRIS) Lists
USDA-sponsored projects.USDA-sponsored projects.
Guide To Searching for Alternatives to the Use of LaboratoryGuide To Searching for Alternatives to the Use of Laboratory
AnimalsAnimals
FRAME (Fund for the Replacement of Animals in MedicalFRAME (Fund for the Replacement of Animals in Medical
Experiments)Experiments)
49. 4949
OrganizationOrganization (6,7, 8,15)(6,7, 8,15)
Alternatives Search Service –Alternatives Search Service –
Alternatives to Skin Irritation Testing in AnimalsAlternatives to Skin Irritation Testing in Animals
ALTWEBALTWEB
Animal Welfare Information CenterAnimal Welfare Information Center
Center for Animal WelfareCenter for Animal Welfare
Centre for the Study of Animal Welfare (CSAW), UniversityCentre for the Study of Animal Welfare (CSAW), University
of Guelphof Guelph
European Centre for the Validation of Alternative MethodsEuropean Centre for the Validation of Alternative Methods
(ECVAM)(ECVAM)
Information on Alternatives Databases - hosted by theInformation on Alternatives Databases - hosted by the
Norwegian Reference Centre for Laboratory Animal ScienceNorwegian Reference Centre for Laboratory Animal Science
and Alternatives.and Alternatives.
Model Organisms for Biomedical Research - Mammalian andModel Organisms for Biomedical Research - Mammalian and
non-mammalian; Funding Opportunities. National Institutes ofnon-mammalian; Funding Opportunities. National Institutes of
Health.Health.
50. 5050
UVA Institutional Animal Care & Use Committee (IACUC)UVA Institutional Animal Care & Use Committee (IACUC)
Animal Welfare Information Center (AWIC) NationalAnimal Welfare Information Center (AWIC) National
Agricultural LibraryAgricultural Library
European Centre for the Validation of Alternative MethodsEuropean Centre for the Validation of Alternative Methods
(ECVAM)(ECVAM)
Fund for the Replacement of Animals in Medical ExperimentsFund for the Replacement of Animals in Medical Experiments
(FRAME)(FRAME)
Institutional Animal Care and Use Committee Training andInstitutional Animal Care and Use Committee Training and
Learning ConsortiumLearning Consortium
Interagency Coordinating Committee for the Evaluation ofInteragency Coordinating Committee for the Evaluation of
Alternative MethodsAlternative Methods
Johns Hopkins Center for Alternatives to Animal TestingJohns Hopkins Center for Alternatives to Animal Testing
(CAAT)(CAAT)
Laboratory Animal Welfare Training ExchangeLaboratory Animal Welfare Training Exchange
Netherlands Center Alternatives to Animal Use (NCA)Netherlands Center Alternatives to Animal Use (NCA)
NORINA (Norwegian Inventory of Alternatives)NORINA (Norwegian Inventory of Alternatives)
Model Organisms for Biomedical ResearchModel Organisms for Biomedical Research
University of California Center for Animal AlternativesUniversity of California Center for Animal Alternatives
51. 5151
ReferencesReferences
1.1. Animal Testing AlternativesAnimal Testing Alternatives,, by Karen Lee Stevens,by Karen Lee Stevens,
Founder & President ALL FOR ANIMALS®. All rightsFounder & President ALL FOR ANIMALS®. All rights
reserved.reserved.
2.2. Animal Resources and Procedures HandbookAnimal Resources and Procedures Handbook
University of Kentucky, ETHICS AND HUMANEUniversity of Kentucky, ETHICS AND HUMANE
CONSIDERATIONS, ALTERNATIVES TO ANIMALCONSIDERATIONS, ALTERNATIVES TO ANIMAL
EXPERIMENTATION.EXPERIMENTATION.
3.3. U.S. Department of Agriculture (USDA), NATIONALU.S. Department of Agriculture (USDA), NATIONAL
AGRICULTURE LIBRARY, ANIMAL INFORMATIONAGRICULTURE LIBRARY, ANIMAL INFORMATION
CENTER.CENTER.
4.4. MSU animal used and care, GUIDELINES FORMSU animal used and care, GUIDELINES FOR
ALTERNATIVES SEARCHING.ALTERNATIVES SEARCHING.
5.5. S G Lisansky and R Macmillan, Alternatives to AnimalS G Lisansky and R Macmillan, Alternatives to Animal
Testing,Testing, CPL Press 1996,388 Pages ISBN 1872691463CPL Press 1996,388 Pages ISBN 1872691463
52. 5252
6.6. Alternatives to Animal Testing: Research, Trends,Alternatives to Animal Testing: Research, Trends,
Validation, Regulatory Acceptance (Download: Part 1, PartValidation, Regulatory Acceptance (Download: Part 1, Part
2, Part 3) Jane Huggins Toxicology Consulting Services,2, Part 3) Jane Huggins Toxicology Consulting Services,
USA-Plainsboro.USA-Plainsboro.
7.7. ALAN M. GOLDBERG, L.F.M. van ZUTPHENALAN M. GOLDBERG, L.F.M. van ZUTPHEN Mary AnnMary Ann
Liebert, IncLiebert, Inc Alternative Methods in Toxicology, Volume 11Alternative Methods in Toxicology, Volume 11
- The World Congress on Alternatives and Animal Use in- The World Congress on Alternatives and Animal Use in
the Life Sciences: Education, Research,the Life Sciences: Education, Research,..
8.8. Richard L. Summers, Steve M. Hudson, and Jean-PierreRichard L. Summers, Steve M. Hudson, and Jean-Pierre
Montana,Montana, Department of Emergency Medicine and theDepartment of Emergency Medicine and the
Department of Physiology, University of MississippiDepartment of Physiology, University of Mississippi
Medical Center, Jackson, Mississippi, Animal WelfareMedical Center, Jackson, Mississippi, Animal Welfare
Information Center Newsletter, Winter 1995/1996, Vol. 6Information Center Newsletter, Winter 1995/1996, Vol. 6
No. 2-4No. 2-4
53. 5353
88 C. Hendriksen, J. Rozing, M. van der Kamp, W. de Leeuw,C. Hendriksen, J. Rozing, M. van der Kamp, W. de Leeuw,
"The production of monoclonal antibodies: Are animals still"The production of monoclonal antibodies: Are animals still
needed?"needed?" Alternatives to Laboratory Animals,Alternatives to Laboratory Animals, 1996;24:109-1996;24:109-
110.110.
99 I.D. Bross, "Mathematical models vs. animal models,"I.D. Bross, "Mathematical models vs. animal models,"
Perspectives on Animal ResearchPerspectives on Animal Research, 1989; 1:83-108; L., 1989; 1:83-108; L.
Blumenson, I. Bross, "A mathematical analysis of theBlumenson, I. Bross, "A mathematical analysis of the
growth and spread of breast cancer,"growth and spread of breast cancer," BiometricsBiometrics,,
1969;25:95-109.1969;25:95-109.
1010 Norina Database http://oslovet.veths.no/NORINA/Norina Database http://oslovet.veths.no/NORINA/
1111 European Resource Centre for Alternatives (EURCA)European Resource Centre for Alternatives (EURCA)
http://www.eurca.org/http://www.eurca.org/
1212 The Principles of Humane Experimental Technique W.M.S.The Principles of Humane Experimental Technique W.M.S.
Russell and R.L. Burch Methuen & Co. Ltd. London 1959.Russell and R.L. Burch Methuen & Co. Ltd. London 1959.
(Special Edition publ. by Universities Federation for Animal(Special Edition publ. by Universities Federation for Animal
Welfare, 1992)Welfare, 1992)
http://altweb.jhsph.edu/publications/humane_exp/het-http://altweb.jhsph.edu/publications/humane_exp/het-
toc.htmtoc.htm
54. 5454
13.13. Balls, M., Goldberg, A.M., Fentem, J.H. et al (1995) TheBalls, M., Goldberg, A.M., Fentem, J.H. et al (1995) The
three Rs: The way forward: ECVAM Workshop Report 11.three Rs: The way forward: ECVAM Workshop Report 11.
ATLA 23: 838-866ATLA 23: 838-866
http://www.ccac.ca/en/CCAC_Programs/ETCC/Module03/0http://www.ccac.ca/en/CCAC_Programs/ETCC/Module03/0
8.html8.html
14.14. Rown A.N., Stratmann C.J.; The use of alternatives inRown A.N., Stratmann C.J.; The use of alternatives in
DRUG RESEACH ; The mechmillan Press Ltd. Delhi;148-DRUG RESEACH ; The mechmillan Press Ltd. Delhi;148-
151.151.
15.15. CRCA (Chancellor’s Animal Research Committee ) USDACRCA (Chancellor’s Animal Research Committee ) USDA
INFORMATIONAL REQUIREMENTS.INFORMATIONAL REQUIREMENTS.
Databases
Many investigators routinely do searches in PubMed, but may not be aware of other databases that can be useful in determining if animal testing alternatives are available. The use of multiple databases to conduct a thorough literature search can be a great way to include all pertinent information on a topic. Some to consider include:
AGRICOLA - Covers every major agricultural subject, including agricultural engineering and marketing, animal breeding, entomology, environmental pollution, farm management, foods and feeds, pesticides, rural sociology, veterinary medicine, and water resources. You may want to use the AGRICOLA Thesaurus for Animal Use Alternatives to find vocabulary for searching alternatives.
ALTBIB - The intent of the bibliography is to assist in identifying methods and procedures helpful in supporting the development, testing, application, and validation of alternatives to the use of vertebrates in biomedical research and toxicology testing.
Biological Abstracts - Provides the most comprehensive coverage of worldwide journal literature in the life sciences including biochemistry, biophysics, experimental medicine, veterinary science, virology, and other topics.
EMBASE - A large biomedical and pharmaceutical database with extensive international coverage of drug research, pharmacology, toxicology, environmental health, clinical and experimental human medicine, and other topics.
National Agricultural Library Alternatives Thesaurus - a listing of over 200 terms in a controlled vocabulary to incorporate new alternatives terminology.
PsycINFO - Accesses worldwide literature in psychology and related disciplines. Includes research on experimental human and animal psychology, physiological psychology, and behavioral research.
Alternatives in Education Database - Association of Veterinarians for Animal Rights (AVAR) Online searchable database of alternatives to harming or killing nonhuman animals used in education.
Altweb Contains reference material and news about all aspects of alternatives in animal research. Includes general, educational, scientific, and regulatory resources. Also contains conference proceedings, books, and reports. Current Research Information System (CRIS) Lists USDA-sponsored projects. Guide To Searching for Alternatives to the Use of Laboratory Animals Includes search basics, terms, strategies, and list of free databases. This guide assumes no previous knowledge of search techniques nor of the facilities available for obtaining information from the Internet. Provided by FRAME (Fund for the Replacement of Animals in Medical Experiments).
CAB Abstract We are running a trial of CAB Abstract until the end of October.
Information on Alternatives Databases Produced by The Norwegian Reference Centre for Laboratory Animal Science and Alternatives. Describes databases addressing all aspects of Replacement, Reduction, and Refinement of animal experiments.
MEDLINE (OVID) Entire MEDLINE database. Covers over 3,000 journals from 1966 to the present.
PubMED Free search service to access over 9 million citations in Biomolecular 3-D Structures, Complete Genomes, MEDLINE, pre-MEDLINE, GenBank DNA Sequences, GenBank Protein Sequences, and other related databases. Access to full-text journal articles is provided via links to participating publishers.
TEXTBASE Produced by The Norwegian School of Veterinary Science, Laboratory Animal Unit. A free searchable database of approximately 740 current textbooks within the field of laboratory animal science.
Transgenic/Targeted Mutation Database (TBASE) A free searchable database of information on transgenic animals and targeted mutations generated and analyzed worldwide.
TOXNET Access to toxicology databases including RTECS, Registry of Toxic Effects of Chemical Substances, and CCRIS, Chemical Carcinogenesis Research Information System.
Web of Science (WOS) Containing Science Citation Index, Social Sciences Citation Index, and Arts & Humanities Citation Index, WOS offers multidisciplinary searching and seamless access to cited reference searching. The WOS databases include bibliographic and citation information for articles from over 5,700 science and engineering journals, 1,700 social sciences journals, and 1,100 arts and humanities journals
ZEBET Database on Alternative Methods to Animal Experiments Available through DIMDI (German Institute for Medical Documentation & Information).